{
    "2019-02-25": [
        [
            {
                "time": "2023-10-05",
                "original_text": "The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Walmart",
                        "Pfizer",
                        "Eli Lilly",
                        "Merck",
                        "Microsoft"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Better Buy: Eli Lilly vs. Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Better Buy",
                        "Eli Lilly",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}